Citizens Financial Group Inc Gsk PLC Transaction History

Citizens Financial Group Inc

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2020 May 08, 2020	SELL	$32.47 - $48.83 $13,020 - $19,580	-401 Closed	0 $0
Q4 2019 Feb 07, 2020	SELL	$42.0 - $48.25 $6,678 - $7,671	-159 Reduced 28.39%	401 $19,000
Q3 2019 Nov 01, 2019	BUY	$40.46 - $43.52 $12,947 - $13,926	320 Added 133.33%	560 $24,000
Q2 2019 Aug 09, 2019	BUY	$39.4 - $42.7 $9,456 - $10,248	240 New	240 $10,000
Q3 2017 Nov 13, 2017	SELL	$39.44 - $41.55 $4,220 - $4,445	-107 Closed	0 $0
Q2 2017 Aug 10, 2017	BUY	N/A	107	107 $5,000

176K

Ticker GSK
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,033,689,984
Market Cap $68.3B
Description
GSK plc, together with its subsidiaries, engages in the creation, discovery, development, manufacture, and marketing of pharmaceutical products, vaccines, over-the-counter medicines, and health-related consumer products in the United Kingdom, the United States, and internationally. It operates through four segments: Pharmaceuticals, Pharmaceutic...

Get notified when there are updates to the investment portfolio of Citizens Financial Group Inc, based on Form 13F filings with the SEC.

Stay updated on Citizens Financial Group Inc with notifications on news.